SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-161413
Filing Date
2019-05-30
Accepted
2019-05-30 17:02:07
Documents
4
Period of Report
2019-05-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d755191d8k.htm 8-K 19725
2 EX-10.1 d755191dex101.htm EX-10.1 39874
3 EX-99.1 d755191dex991.htm EX-99.1 10540
4 GRAPHIC g755191g0530035504483.jpg GRAPHIC 4937
  Complete submission text file 0001193125-19-161413.txt   78515
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 19867351
SIC: 2834 Pharmaceutical Preparations